← All organizations

Immodulon Therapeutics Ltd

For profitWebsite ↗

Also known as: Immodulon Therapeutics Ltd

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Nov 15, 2021

Timeline

2000s

Jun 1, 2007
Immodulon Therapeutics Ltd— Founded

Drugs by trial phase (14 distinct, 9 trials)

Phase 3 (1 own, 0 via acquisition)

Inactivated Mycobacterium obuense

Phase 2 (13 own, 0 via acquisition)

Indications

Studied for

Recent trials (9)

NCT04137822CollaboratorN/A—
NCT05118724CollaboratorPhase 2Nov 15, 2021
NCT04442048CollaboratorPhase 3Jun 25, 2020
NCT03711188Lead sponsorPhase 2Oct 4, 2018
NCT03009058Lead sponsorPhase 1/Phase 2May 24, 2017
NCT01559818Lead sponsorPhase 1/Phase 2Feb 1, 2012
NCT01539824Lead sponsorPhase 2Feb 1, 2012
NCT01303172Lead sponsorPhase 2Jun 1, 2011
NCT01308762Lead sponsorPhase 1Mar 1, 2010

Details

Founded: London, GB Jun 1, 2007
Last known activity: Nov 15, 2021